Virology
TWiV 951: Clinical update with Dr. Daniel Griffin
By Vincent Racaniello | | This Week in Virology
In his weekly clinical update Dr. Griffin discusses Influenza incidence and vaccine effectiveness during the southern hemisphere influenza season in Chile, Nirsevimab for prevention of RSV infection in healthy late-preterm and term infants, severe Monkeypox in hospitalized patients, reinfections with different SARS-CoV-2 Omicron subvariants, impact of community masking on COVID-19 in Bangladesh, unadjuvanted intranasal spike vaccine elicits protective …
TWiV 951: Clinical update with Dr. Daniel Griffin Read More »
Antibodies Against SARS-CoV-2 Nucleocapsid Protein May Not Be Reliable Markers for Infection in Vaccinated People
By Gertrud U. Rey | | Basic virology, Gertrud Rey
by Gertrud U. Rey You are fully vaccinated against SARS-CoV-2 and have presumably never been infected with the virus. But how can you know for sure? One way to find out is by testing your blood for the presence of antibodies against the viral nucleocapsid protein, which can only be encountered during natural infection. This …
TWiV 950: Prion diseases with Richard Knight
By Vincent Racaniello | | This Week in Virology
From the European Society for Clinical Virology 2022 Conference in Manchester UK, Vincent speaks with Richard Knight about prion diseases and the outbreak of bovine spongiform encephalitis that led to cases of variant Creutzfeldt-Jakob disease in humans. Host: Vincent Racaniello Guest: Richard Knight Click arrow to playDownload TWiV 950 (68 MB .mp3, 114 min)Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become …
TWiV 949: Clinical update with Dr. Daniel Griffin
By Vincent Racaniello | | This Week in Virology
In his weekly clinical update Dr. Griffin discusses progress toward poliomyelitis eradication in Pakistan, polio by the numbers , influenza and COVID-19 vaccination coverage among health care personnel, phase 1/2a safety and immunogenicity of an adenovirus 26 vector RSV vaccine encoding prefusion F in adults 18–50 years and RSV seropositive children 12–24 months, receipt of first and second doses of JYNNEOS vaccine for prevention of Monkeypox, distinguishing SARS-CoV-2 persistence and reinfection, Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages, association between regular physical activity and the protective effect of vaccination against SARS-CoV-2 in a South African case, COVID-19 outcomes in solid organ transplant recipients who received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab treatment, Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralizing antibodies, and Tocilizumab versus Baricitinib in hospitalized patients with severe COVID-19.
TWiV 948: Breathless with David Quammen
By Vincent Racaniello | | This Week in Virology
David Quammen returns to TWiV to discuss how he wrote his new book 'Breathless', a story about the science and the scientists behind the race to understand the pandemic coronavirus SARS-CoV-2.
TWiV 947: Clinical update with Dr. Daniel Griffin
By Vincent Racaniello | | This Week in Virology
In his weekly clinical update Dr. Griffin discusses the prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic, severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters, and how successful immunomodulators for treatment of COVID-19 have opened the pathway for comparative trials.
David Tuller
Trial By Error: Anil van der Zee’s New Video on Living with Severe ME
By David Tuller, DrPH *This is a crowdfunding month for Trial By Error. Donations (tax-deductible to US tax-payers) go to the University of Calinfornia, Berkeley, to support the project. The link to the crowdfunding campaign is here: https://crowdfund.berkeley.edu/project/42302 ********** Anil van der Zee and I first connected in 2016, when he invited me to Amsterdam to …
Trial By Error: Anil van der Zee’s New Video on Living with Severe ME Read More »
Trial By Error: Time’s Health100 List Includes Leaders in Long Covid and ME/CFS
By David Tuller, DrPH *This is a crowdfunding month for Trial By Error. Donations (tax-deductible to US tax-payers) go to the University of Calinfornia, Berkeley, to support the project. The link to the crowdfunding campaign is here: https://crowdfund.berkeley.edu/project/42302 Last week, Time magazine unveiled a list called the TIME100 Health—a selection of “leaders from across industries—scientists, doctors, …
Trial By Error: Time’s Health100 List Includes Leaders in Long Covid and ME/CFS Read More »
Trial By Error: A Conversation with the Co-Founders of The Sick Times
By David Tuller, DrPH *This is a crowdfunding month for Trial By Error. Donations (tax-deductible to US tax-payers) go to the University of Calinfornia, Berkeley, to support the project. The link to the crowdfunding campaign is here: https://crowdfund.berkeley.edu/project/42302 Journalists Betsy Ladyzhets and Miles Griffis are the co-founders of The Sick Times, a non-profit that covers …
Trial By Error: A Conversation with the Co-Founders of The Sick Times Read More »
Trial By Error: Interview with Co-Organizator of Next Week’s Unite To Fight Long Covid and ME/CFS Conference
By David Tuller, DrPH *This is a crowdfunding month at Berkeley for Trial By Error. If you appreciate my work, here’s a link to donate (tax-deductible to US taxpayers) directly to the university: https://crowdfund.berkeley.edu/project/42302 ********** Marco Wetzel, a digital sales expert, is one of five German Long Covid patients who banded together earlier this year …
Trial By Error: Berkeley’s May Crowdfunding Campaign Begins…
By David Tuller, DrPH Berkeley’s latest crowdfunding campaign for Trial By Error begins today. It is hard for me to believe that I have been working on this project—debunking awful research into what was then called “chronic fatigue syndrome,” and related issues–for ten years. My efforts began in the summer of 2014, when I traveled …
Trial By Error: Berkeley’s May Crowdfunding Campaign Begins… Read More »
Trial By Error: Australian GP Group Recommends “Incremental Physical Activity” for “CFS/ME” Patients
By David Tuller, DrPH What’s going on with Aussie members of the graded exercise therapy cult? (Oops!—I meant the Royal Australian College of General Practitioners, a trade and professional organization. Sorry!) In 2019, I wrote about the organization’s guidance for “CFS/ME.” This guidance, published in 2015, was part of the group’s Handbook of Non-Drug Interventions …